NCT01677624View on ClinicalTrials.gov

A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
Hypervascular Tumor and Arteriovenous Malformation
Interventions
DEVICE

E7040

E7040 of optimal particle size (-300 um, 300-500 um, or 500-700 um to fit in a target vessel, target lesion, or embolized area) as transcatheter study device will be administered .

Trial Locations (10)

Unknown

Hirosaki

Chikushino-shi

Kurume

Nishinomiya

Kanazawa

Kagoshima

Tsu

Okayama

Chuo-ku

Minato-ku

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT01677624 - A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation | Biotech Hunter | Biotech Hunter